In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023-24 season vaccination campaigns in the European Union/European Economic Area (EU/EEA). This report presents an interim description of COVID-19 vaccine...

Cervical cancer is the fourth most common cancer affecting women worldwide. It is caused by persistent infection with oncogenic types of human papillomavirus (HPV). More than 200 types of HPV have been identified and more than 40 types of them infect the genital tract. HPV 16 and 18 are the two...

In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023-24 season vaccination campaigns. This report presents an interim description of COVID-19 vaccine coverage in the European Union/European Economic Area...

With Europe's Beating Cancer Plan, the European Commission is supporting effective cancer strategies that can prevent illness, save lives and reduce the impacts of cancer. This includes a Flagship Initiative to address cancers that can be prevented by vaccination, namely cancers caused by Human...

Seasonal influenza is a respiratory infectious disease that spreads globally through annual epidemics and occasional pandemics. Vaccination is the most effective means for preventing influenza infection. However, the effectiveness of influenza vaccines varies to some degree from season to...

The end of 2019 saw the emergence of a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19). As of October 2023, almost 276 million cases and more than 2.2 million deaths had been reported in the WHO European Region [1]. As of October...